Acetazolamide sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for acetazolamide sodium and what is the scope of freedom to operate?
Acetazolamide sodium
is the generic ingredient in two branded drugs marketed by Avet Lifesciences, Endo Operations, Hikma, Hospira, Mylan Asi, Xgen Pharms, Zydus Pharms, and Teva Womens, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.Six suppliers are listed for this compound.
Summary for acetazolamide sodium
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 8 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 9 |
Clinical Trials: | 9 |
Patent Applications: | 333 |
What excipients (inactive ingredients) are in acetazolamide sodium? | acetazolamide sodium excipients list |
DailyMed Link: | acetazolamide sodium at DailyMed |
Recent Clinical Trials for acetazolamide sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Leona M. and Harry B. Helmsley Charitable Trust | Phase 1/Phase 2 |
JDRF | Phase 1/Phase 2 |
University of California, San Diego | Phase 1/Phase 2 |
Pharmacology for acetazolamide sodium
Drug Class | Carbonic Anhydrase Inhibitor |
Mechanism of Action | Carbonic Anhydrase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for acetazolamide sodium
US Patents and Regulatory Information for acetazolamide sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 206533-001 | Apr 15, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Avet Lifesciences | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 202693-001 | Dec 19, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Mylan Asi | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 200880-001 | May 9, 2012 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hospira | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 040108-001 | Oct 30, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hikma | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 040089-001 | Feb 28, 1995 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.